Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,726 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, Not Recruiting

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT06637371

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Orange County Research Center Lake Forest, California, United States
  • Translational Clinical Research LLC Aventura, Florida, United States
  • Destiny Research Center Palmetto Bay, Florida, United States
  • ClinCept, LLC Columbus, Georgia, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT06832618

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Saguaro Dermatology Phoenix, Arizona, United States
  • National Jewish Health Denver, Colorado, United States
  • Encore Medical Research, Llc Hollywood Hollywood, Florida, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

NCT06473779

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Research Site Palmdale, California, United States
  • Research Site Colorado Springs, Colorado, United States
  • Research Site Miami, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 70 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

NCT05976243

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +11 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Acuro Research Inc Little Rock, Arkansas, United States
  • Kern Research Bakersfield, California, United States
  • Allergy and Asthma Specialists Group Huntington Beach, California, United States
View all 131 locations
View Trial Details
Active, Not Recruiting

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

NCT07027527

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Darlinghurst, New South Wales, Australia
  • Investigational Site Kogarah, New South Wales, Australia
  • Investigational Site Westmead, New South Wales, Australia
  • Investigational Site Woolloongabba, Queensland, Australia
View all 20 locations
View Trial Details

Related conditions